Archived government news
April 2024
Correspondence: ACMD work programme 2024 Friday, 05 April 2024
Research: ACMD advice on 2-benzyl benzimidazole and piperidine benzimidazol… Friday, 05 April 2024
March 2024
Research: Uncontrolled novel benzodiazepines: 2024 update Thursday, 28 March 2024
Research: Uncontrolled novel benzodiazepines: 2024 update Thursday, 28 March 2024
Research: ACMD advice on acyl piperazine opioids, including 2-methyl-AP-237 Wednesday, 27 March 2024
Research: ACMD advice on acyl piperazine opioids, including 2-methyl-AP-237 Wednesday, 27 March 2024
Correspondence: Response to the third addendum to the ACMD report on 2-benz… Thursday, 21 March 2024
February 2024
Research: Use and harms of xylazine, medetomidine and detomidine Friday, 23 February 2024
Research: Use and harms of xylazine, medetomidine and detomidine Friday, 16 February 2024
Research: Use and harms of xylazine, medetomidine and detomidine Friday, 16 February 2024
Correspondence: ACMD work programme 2024 Wednesday, 14 February 2024
Research: Consideration of barriers to research: part 2 Tuesday, 06 February 2024
January 2024
Open call for evidence: Drug prevention policies and landscape across the U… Friday, 05 January 2024
December 2023
Research: Consideration of barriers to research: part 2 Friday, 22 December 2023
Open call for evidence: ACMD internet-facilitated drug markets review Wednesday, 20 December 2023
Research: ACMD advice on 2-benzyl benzimidazole and piperidine benzimidazol… Friday, 15 December 2023
November 2023
Fifteen new synthetic opioids to be made illegal Monday, 27 November 2023
Open call for evidence: ACMD internet-facilitated drug markets review Friday, 17 November 2023
October 2023
Research: ACMD advice on consumer cannabidiol (CBD) products Tuesday, 24 October 2023
Correspondence: Barriers to research with synthetic cannabinoid receptor ag… Monday, 23 October 2023
Research: ACMD advice on 2-benzyl benzimidazole and piperidine benzimidazol… Wednesday, 18 October 2023
Research: ACMD advice on 2-benzyl benzimidazole and piperidine benzimidazol… Friday, 06 October 2023
September 2023
Research: ACMD Naloxone Review Tuesday, 26 September 2023
Open call for evidence: Drug use in ethnic minority groups Thursday, 21 September 2023
Research: Advice on scheduling and lawful access to nitrous oxide Tuesday, 05 September 2023
Reappointments to the Advisory Council on the Misuse of Drugs Monday, 04 September 2023
August 2023
Correspondence: Powder cocaine use in young people and adults: call for evi… Wednesday, 30 August 2023
Research: Advice on scheduling and lawful access to nitrous oxide Friday, 11 August 2023
Recruiting: Advisory Council on the Misuse of Drugs members Wednesday, 02 August 2023
July 2023
Correspondence: Preventing drug use in young people: commissioning letter Thursday, 27 July 2023
Correspondence: Powder cocaine use in young people and adults: call for evi… Thursday, 27 July 2023
Correspondence: The use and harms of Cumyl-PeGaClone Tuesday, 25 July 2023
Correspondence: The use and harms of Cumyl-PeGaClone Tuesday, 25 July 2023
Correspondence: ACMD advice on NHS England electronic prescribing proposal Monday, 03 July 2023
June 2023
Correspondence: ACMD advice on NHS England electronic prescribing proposal Friday, 30 June 2023
Research: Nitrous oxide: updated harms assessment Thursday, 22 June 2023
Research: Nitrous oxide: updated harms assessment Tuesday, 20 June 2023
Research: Nitrous oxide: updated harms assessment Friday, 16 June 2023
Research: ACMD review of the evidence on the use and harms of Cumyl-PeGaClo… Thursday, 08 June 2023
May 2023
Research: ACMD review of the evidence on the use and harms of diphenidine Friday, 26 May 2023
Research: ACMD review of the evidence on the use and harms of diphenidine Thursday, 25 May 2023
Research: ACMD review of the evidence on the use and harms of Cumyl-PeGaClo… Thursday, 25 May 2023
Correspondence: Synthetic cathinones: letter asking for updated harms asses… Thursday, 11 May 2023
March 2023
Research: Nitrous oxide: updated harms assessment Monday, 27 March 2023
Research: Nitrous oxide: updated harms assessment Tuesday, 07 March 2023
Publication of ACMD’s review on nitrous oxide Monday, 06 March 2023
Publication of ACMD’s review on nitrous oxide Monday, 06 March 2023
Research: Nitrous oxide: updated harms assessment Monday, 06 March 2023
February 2023
Correspondence: ACMD Nitrous Oxide: public call for evidence Wednesday, 08 February 2023
Correspondence: Nitrous Oxide: Home Secretary's letter to the ACMD Tuesday, 07 February 2023
Research: ACMD advice on 2-benzyl benzimidazole and piperidine benzimidazol… Friday, 03 February 2023
December 2022
Research: ACMD advice on 2-benzyl benzimidazole and piperidine benzimidazol… Monday, 19 December 2022
Research: Consideration of barriers to research: part 1 Monday, 12 December 2022
Correspondence: Barriers to research with synthetic cannabinoid receptor ag… Monday, 12 December 2022
Correspondence: ACMD vulnerable groups: young people’s drug use Friday, 09 December 2022
Correspondence: AMCD vulnerable groups: young people’s drug use Friday, 09 December 2022
Research: Synthetic cannabinoid receptor agonists Tuesday, 06 December 2022
Correspondence: ACMD advice on the classification and schedule of Remimazol… Friday, 02 December 2022
October 2022
Correspondence: ACMD advice on administration rights for therapeutic radiog… Monday, 03 October 2022
Correspondence: ACMD advice on independent prescribing by paramedics Monday, 03 October 2022
Correspondence: Independent prescribing by paramedics and administration ri… Monday, 03 October 2022
July 2022
Research: ACMD advice on 2-benzyl benzimidazole and piperidine benzimidazol… Monday, 18 July 2022
June 2022
Publication of the ACMD report into the availability and use of naloxone Friday, 17 June 2022
Research: ACMD Naloxone Review Friday, 17 June 2022
Research: ACMD Naloxone Review Friday, 17 June 2022
Correspondence: ACMD advice on the interim podiatrists supply proposal from… Tuesday, 14 June 2022
May 2022
Research: Drug misuse prevention review Wednesday, 18 May 2022
Publication of the drug misuse prevention review Tuesday, 17 May 2022
September 2017
ACMD warns ministers of falling local funding for drug treatment services Wednesday, 06 September 2017
August 2017
Image and Performance Enhancing Drugs: public evidence gathering day Wednesday, 16 August 2017
April 2017
Now recruiting: Advisory Council on the Misuse of Drugs members Monday, 03 April 2017
June 2016
Advisory Council on the Misuse of Drugs recruiting new chair Friday, 24 June 2016
October 2015
Quality of treatment for heroin users under threat Friday, 23 October 2015
March 2015
ACMD publishes major cocaine report Thursday, 12 March 2015
February 2015
ACMD paper highlights substance abuse knowledge gap Wednesday, 25 February 2015
November 2014
New drug description to help ban family of legal highs Thursday, 27 November 2014
ACMD recommends ban for two legal highs linked to deaths Friday, 14 November 2014
June 2014
Deadly "legal highs" which mimic Class A drugs to be banned Tuesday, 10 June 2014
ACMD public event: open meeting on 12 June 2014 Thursday, 05 June 2014
April 2014
ACMD public event: open meeting on 11 April 2014 Tuesday, 01 April 2014
December 2013
New evidence of harm caused by ketamine misuse Tuesday, 10 December 2013
Drug recovery is a long battle, warns the ACMD Tuesday, 03 December 2013
November 2013
ACMD recommends permanent ban on two “legal highs” Thursday, 28 November 2013
September 2013
ACMD advises the government on the control of prescription drugs Thursday, 05 September 2013
May 2013
ACMD public event: open meeting on 16 May 2013 Wednesday, 08 May 2013
March 2012
The new home on the web for the Advisory Council on the Misuse of Drugs Tuesday, 27 March 2012